RIM
SAGE

RS Investment Management’s Sage Therapeutics SAGE Stock Holding History

RS Investment Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$17.7M Buy
586,826
+10,435
+2% +$348K 0.18% 194
2016
Q1 		$18.5M Buy
576,391
+71,986
+14% +$2.53M 0.18% 186
2015
Q4 		$29.4M Buy
504,405
+64,567
+15% +$3.2M 0.26% 134
2015
Q3 		$18.6M Buy
439,838
+59,360
+16% +$3.66M 0.17% 188
2015
Q2 		$27.8M Buy
380,478
+23,400
+7% +$1.5M 0.24% 155
2015
Q1 		$17.9M Buy
357,078
+3,020
+0.9% +$130K 0.16% 197
2014
Q4 		$13M Buy
354,058
+64,958
+22% +$2.42M 0.12% 226
2014
Q3 		$9.11M Buy
+289,100
New +$8.38M 0.08% 242

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

RS Investment Management's SAGE Position: Q2 2016 in Review

RS Investment Management increased its Sage Therapeutics (SAGE) stake by 1.8% in Q2 2016, buying an estimated $348K and bringing the position to 586,826 shares worth $17.7M. The position accounts for 0.18% of the portfolio, ranked #194.

RS Investment Management first reported a position in SAGE in Q3 2014 and has held it in 8 quarters since. The position peaked at $29.4M in Q4 2015. 145 funds tracked by Wall St. Rank hold SAGE as of Q2 2016.

  • RS Investment Management held 586,826 shares of Sage Therapeutics worth $17.7M as of Q2 2016.
  • RS Investment Management bought 10,435 Sage Therapeutics shares in Q2 2016, an estimated $348K.
  • Sage Therapeutics made up 0.18% of RS Investment Management's portfolio in Q2 2016, its #194 holding.
  • RS Investment Management first reported a position in Sage Therapeutics in Q3 2014 and has held it in 8 quarters since.
  • RS Investment Management's Sage Therapeutics position peaked at $29.4M in Q4 2015.
  • 145 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.